# Labdan derivatives, a process for their preparation and their use as medicaments.

## Abstract
The present invention relates to novel labdanes, inter mediates and processes for the preparation thereof. The compounds have the ability to reduce elevated in traocular pressure and can, therefore, be used as medica ments.

## Claims
Claims 1. A compound of the formulaEMI41.1 wherein a R1 is hydrogen, a group of the formula R2CO wherein R2 is hydrogen or loweralkyl, or a group of the formula R3RR5Si wherein R3, R4 and R5 are each independently loweralkyl b R6 and R7 are each independently hydrogen, a group of the formula R8CO wherein R8 is hydrogen, loweralkyl,EMI41.2 CH3CHOH, HOCH2CHOH,EMI41.3 group of the formula R16O CH2 n wherein R18 is hydrogen or loweralkyl and n is 1, 2 or 3, a group of the formula R11R12NCHR13 wherein R11 is hydrogen, loweralkyl, a group of the formulaEMI41.4 a group of the formulaEMI41.5 or a g roup of the formulaR14CO wherein R14 is hydrogen or loweralkyl Rl2 is hydrogen or loweralkyl R13 is hydrogen, loweralkyl, benzyl or a group of the formula CH20H R11 and R12 taken together with the nitrogen atom to which they are attached form a group of the formulaEMI41.6 rein X isCHR15 wherein R15 is hydrogen, loweralkyl or a group of the formula OR16 wherein R16 is hydrogen, loweralkyl or a group of the formula COR17 wherein R17 is ioweralkyl, and m is 9 or 1 a group of the formula NR18 wherein R18 is loweralkyl dnd R6.and R7 taken together form a group of the formula CO or a group of the formula SO c Rg is hydrogen d R1 and Rg taken together form a group of the formula CO, a group of the formula SO or a group of the formula CHNR19R28 wherein R19 and R28 are each independently loweralkyl and R19 and R2 taken together with the nitrogen atom to which they are attached form a group of the formulaEMI42.1 rein X and m are as hereinbeforedescribed with the provisos e that R6 is not hydrogen or R8CO wherein R8 is hydrogen or loweralkyl when R7 is hydrogen or R8CO wherein R8 is hydrogen or loweralkyl R1 is hydrogen, ,R2CO or R3R4R5Si wherein R3, R4 and R5 are as above and R9 is hydrogen f that R1 is not hydrogen or R2CO when Rg is hydrogen and R6 and R7 taken together are Co g that R1 and Rg taken together are not Co or SO when R6 is hydrogen or R8CO wherein R8 is hydrogen or loweralkyl and R7 is hydrogen or R8CO wherein R8 is hydrogen or lowerlakyl or when R6 and R7 taken together are CO or SO the optical and geometric isomers thereof, or a pharmaceutically acceptable acid addition salt thereof. 2. A compound according to claim 1 wherein R1 and R9 are hydrogen and R6 is a group of the formula R8CO wherein R8 is a group of the formula R11R12NCHR13 wherein R11, R12 and R13 are as hereinbeforedefined. 3. A compound according to claim 1 wherein R1 and R9 are hydrogen and R7 is a group of the formula R8CO wherein R8 is group of the formula R11R12NCHR13 wherein R11, R12 and R13 are as hereinbeforedefined. 4. A compound according to claim 1 wherein R1 and Rg are hydrogen and R6 is R8CO wherein R8 is a group of the formulaO OHC, CH3C, CH3CHOH, HOCH2CHOH,EMI43.1 and a group of the formula R18O CH2 n wherein Rl is hydrogen or loweralkyl and n is 1, 2 or 3. 5. A compound according to claim 1 wherein R1 and Rg are hydrogen and R7 is a group of the formula R8CO wherein, is a group of the formulaEMI43.2 CH3CHOH, HOCH2CHOH,EMI43.3 EMI43.4 and a group of the formula R18O CH2 n wherein R1g is hydrogen or loweralkyl and n is 1, 2 or 3. 6. A compound according to claim 1 wherein R1 and R9 taken together form a group of the formula CENR19R28 wherein R19 and R28 are as hereinbeforedefined. 7. The e compound of claim 3 which is 7ss N,N diethylamino acetoxy 8,13 epoxy 1 alpha ,6ss,2 alpha trihydroxyslabd 14 en 11 one. 1,9 dimethylformamide acetal. 8. The compound of claim 3 which is 7ss N,N dimethylamino acetoxy 1,13 epoxy 1 alpha ,6ss,2 alpha trihydroxylabd 14 en 11 one. The compound of claim 3 which is g N,N diethylamino acetoxy 8,13 epoxy 1 alpha ,6ss,2 alpha trihydroxylabd 14 en 11 one. 10. The compound of claim 3 which is 7ss 2 N t butoxy carboyl aminopropanoyloxy 8,13 epoxy 1 alpha ,6ss,2 alpha trihydroxy labd 14 en one. 11. The compound of claim 3 which is 7ss N acetylaminoacetoxy 8,13 epoxy 3 alpha 6ss,2 alpha trihydroxylabd 14 en 11 one. 12. A compound of claim 4 which is 8,13 epoxy 1 alpha ,6ss,2 alpha trihydroxy 7ss 2 tetrahydrofuranoyloxy labd 14 en 11 one. 13. A pharmaceutical composition which comprises as active ingredient a compound as defined in claim 1 in associa tion with a pharmaceutically acceptable carrier 14. Use of a compound as defined in claim 1 for the prepared tion of a medicament useful in the treatment of elevated intraocular pressure. 15. A process for the preparation of a compound of the formulaEMI44.1 wherein a R1 is hydrogen, a group of the formula R2CO wherein R2 is hydrogen or loweralkyl, or a group of the formula R3R4RsSi wherein R3, R4 and R5 are each independently loweralkyl b R6 and R7 are each independently hydrogen, a group of the formula R8CO wherein R8 is hydrogen, loweralkyl,EMI44.2 CH3CHOH, HOCH2CHOH,EMI44.3 group of the formula R16O CH2 n wherein R10 is hydrogen or loweralkyl and n is 1, 2 or 3, a group of the formula R11R12NCHR13 wherein Ril is hydrogen, loweralkyl, a group of the formulaEMI44.4 a group of the formulaEMI44.5 or a group of the formulaR14CO wherein R14 is hydrogen or loweralkyl R12 is hydrogen or loweralkyl R13 is hydrogen, loweralkyl, benzyl or a group of the formula CH20 R11 and R12 taken together with the nitrogen atom to which they are attached form a group of the formulaEMI44.6 rein X isCHR15 wherein R15 is hydrogen, loweralkyl or a group of the formula OR16 wherein R16 is hydrogen, loweralkyl or a group of the formula COR17 wherein R17 is loweralkyl, ,and m is 8 or 1 a group of the formula NR18 wherein R18 is loweralkyl and R6 and R7 taken together form a group of the formula CO or a group of the formula So c R9 is hydrogen d R1 and R9 taken together form a group of the formula CO, a group of the formula SO or a group of the formula CHNR19R28 wherein R19 and R2g are each independently loweralkyl and R19 and R28 taken together with the nitroqen atom to which they are attached form a qrouP of the formulaEMI45.1 rein X and m are as hereinbeforedescribed with the provisos e that R6 is not hydrogen or R8CO wherein R8 is hydrogen or loweralkyl when R7 is hydrogen or R8CO wherein R8 is hydrogen or loweralkyl R1 is hydrogen, R2CO or R3R4R5Si wherein R3, R4 and R5 are as above and Rg is hydrogen f that R1 is not hydrogen or R2CO when Rg is hydrogen and R6 and R7 taken together are CO g that R1 andR9 taken together are not CO or SO when R6 is hydrogen or R8CO wherein R8 is hydrogen or loweralkyl and R7 is hydrogen or R8CO wherein R8 is hydrogen or lowerlakyl or when R6 and R7 taken together are CO or SO the optical and geometric isomers thereof, or a pharmaceutically acceptable acid addition salt thereof which comprises a condensing a compound of the formula 2EMI45.2 wherein R7 is lower alkanoyl, with a formamid dialkylacetal of formula 10 EMI46.1 wherein R21 is lower alkyl and R19 and R20 are each independently loweralkyl, to provide a compound of the invention of the formula 3EMI46.2 wherein R7, R19 and R20 are as hereinbefore defined b optionally rearranging a compound of the formula 3 to obtain a compound of the invention of the formula 4EMI46.3 wherein R6 is loweralkanoyl and R19 and R20 are in dependently loweralkyl, c optionally hydrolyzing a compound of the formula 3 or 4 to provide a compound of the invention of the formula 5EMI46.4 wherein R19 and R20 are independently loweralkyl, d optionally treating a compound of the formula 5 with a compound of the formula Ral Z Ral, wherein Hal is bromo or chloro and Z is SO or CO to pro vide a compound of the invention of the formula 7 EMI47.1 wherein Z is SO or CO and R19 and R20 are indepen dently loweralkyl, e optionally esterifying a compound of the formula 5 with an aminoacid of formula 12 R11R12NCHR13COOH 12 wherein R11, R12 and R13 are as defined above, to provide a comp ound of the invention of the formula 6EMI47.2 wherein R19 and R20 are independently loweralkyl,R11 is hydrogen, loweralkyl, a group of the formulaEMI47.3 a group of the formulaEMI47.4 or a group of the formula R14CO wherein R14 is hydrogen or loweralkyl R12 is hydrogen or loweralkyl R13 is hydrogen, loweralkyl, benzyl or a group of the formula CH20H R1l and R12 taken together with the nitrogen atom to which they are attached form a group of the formulaEMI47.5 rein X is CHR15 wherein Rz5 is hydrogen, loweralkyl or a group of the formula OR16 wherein R16 is hydrogen, loweralkyl or a group of the formula COR17 wherein R17 is loweralkyl and m is g or It a group of the formula NR18 wherein R18 is lower alkyl, f optionally hydrolyzing a compound of the formula 6 or esterifying a compound of the formula 8EMI48.1 with a compound of the formula 12 R11R12NCHR13COOH 12 wherein R11, R12 and R13 are as hereinbefore defined, in a way described in step e above to provide a compound of the invention of the formula 9EMI48.2 g optionally treating a compound of the formula 2EMI48.3 with a N trialkylsilyl N alkyltrifluoroacetamide of formula 16EMI48.4 wherein R3, R4 and R are as defined above and R23 is alkyl, to provide a compound of the inventionOf the formula 13EMI49.1 wherein R7 is lower alkanoyl, and R3, R4 and R5 are each independently lower alkyl, h optionally hydrolyzing a compound of the formula 13 to provide a compound of the invention 14EMI49.2 wherein R3, R4 and R5 are eacn independently lower alkyl, j optionally treating a compound of the formula 14 with an aminoacid of the formula R11R12NCHR13COOH 12 to provide a compound of the invention of the formula 15EMI49.3 wherein R3, R4, R5, R11, R12 and 13 are as defined abov e, or k optionally treating a compound of the formula 14 with a compound of the formula Hal Z Eal, wherein Bal is bromo or chloro and Z is SO or CO to pro vide a compound of the invention of the formula 16EMI50.1 wherein R3, R4, R5 and Z are as defined above, optionally removing the silyl group in a compound of the formula 16 by treating it with aqueous hydrogen fluoride to provide a compound of the invention of the formula 17EMI50.2 wherein Z is as defined above, and m optionally removing the silyl group in a compound of the formula 15 to provide a compound of the in vention of the formula 9EMI50.3 wherein R11, R12 and R13 are as defined above.

## Description
The present invention relates to labdanes. More particularly, the present invention relates to labdanes of formula IEMI1.1 wherein a R1 is hydrogen, a group of the formula R2CO wherein R2 is hydrogen or loweralkyl, or a group of the formula R3R4R5Si wherein R3, R4 and R5 are each independently loweralkyl b R6 and R7 are each independently hydrogen, a group of the formula R8CO wherein R8 is hydrogen, loweralkyl,EMI1.2 CH3CHOH, HOCH2CHOH,EMI1.3 group of the formula RlO CH2 n wherein R,0 is hydrogen or loweralkyl and n is 1, 2 or 3, a group of the formula R11R12NCHR13 wherein R11 in hydrogen, loweralkyl, a grouP of the formulaEMI1.4 a group of the formulaEMI1.5 or a group of the formula R14CO wherein R14 is hydrogen or loweralkyl R12 is hydrogen or loweralkyl R13 is hydrogen, loweralkyl, benzyl or a group of the formula CH20H R11 and R12 taken together with the nitrogen atom to which they are attached form a group of the formula EMI2.1 erein X is CHR15 wherein R15 is hydrogen, loweralkyl or a group of the formula OR16 wherein R16 is hydrogen, loweralkyl or a group of the formula CORl7 wherein Rl7 is loweralkyl and m is 0 or 1 a group of the formula NRl8 wherein Rl8 is loweralkyl and R6 and R7 taken together form a group of the formula CO or a group of the formula SO c Rg is hydrogen d R1 and Rg taken together form a group of the formula CO, a group of the formula SO or a group of the formula CHNR19R20 wherein R19 and R20 are each independently loweralkyl and R19 and R2 taken together with the nitrogen atom to which they are attached form a group of the formulaEMI2.2 whe rein X and m are as hereinbeforedescribed with the provisos e that R6 is not hydrogen or R8CO wherein R8 is hydrogen or loweralkyl when R7 is hydrogen or R8CO wherein R8 is hydrogen or loweralkyl R1 is hydrogen, R2CO or R3R4R5Si wherein R3,Ro and R5 are as above and Rg is hydrogen f that R1 is not hydrogen or R2CO when Rg is hydrogen and R6 and R7 taken together are CO g that R1 and R9 taken together are not CO or SO when R6 is hydrogen or R8CO wherein R8 is hydrogen or loweralkyl and R7 is hydrogen or R8CO wherein R8 is hydrogen or loweralkyl or when R6 and R7 taken together are CO or SO the optical and geometric isomers thereof, or a pharmaceutically acceptable acid addition salt thereof, which are useful for reducing intraocular pressure, alone or in combination with inert adjuvants. Subgeneric to the labdanes of the present invention are compounds of formula I wherein a R1 and Rg are hydrogen and R6 is a group of the formula R8CO wherein R8 is a group of the formula R11R12NCHR13 wherein R11, R12 and R13 are as hereinbeforedefined b R1 and R9 are hydrogen and R7 is a group of the formula R8CO wherein R8 is a group of the formula R11R12NCHR13 wherein R11, Rl2 and Rl3 are as hereinbeforedefined c R1 and Rg are hydrogen and R6 is R8CO wherein R8 is a group of the formulaEMI3.1 CH3CHOH, HOCH2CHOH,EMI3.2 and a group of the formula R10O CH2 n wherein R10 is hydrogen or loweralkyl and n is 1, 2 or 3 d R1 and Rg are hydrogen and R7 is a group of the formula R8CO wherein R8 is a group of the formulaEMI3.3 CH3CHOH, HOCH2CHOH, EMI3.4 and a group of the formula R10O CH2 n wherein R10 is hydrogen or loweralkyl and n is 1, 2 or 3 and e R1 and Rg taken together form a group of the formula CHNR19R20 wherein R19 and R2 are as hereinbefore defined As used through the specification and appended claims, the term alkyl refers to a straight or branched chain hydrocarbon radical containing no unsaturation and having 1 to 8 carbon atoms such as methyl, ethyl, l propyl, 2 propyl, l butyl, l pentyl, 2 pentyl, 3 hexyl, 4 heptyl, 2 octyl, and the like the term alkanol1 refers to a compound formed by a combination of an alkyl group and a hydroxy radical. Examples of alkanols are methanol, ethanol, 1 and 2 propanol, 1,2 dimethylethanol, hexanol, octanol and the like. The term alkanoic acid refers to a compound formed by combination of a carboxyl group with a hydrogen atom or alkyl group. Examples of alkanoic acids are forme acid, acetic acid, propanoic acid, 2,2 dimethylacetic acid, hexanoic acid, octanoic acid, and the like the term halogen1 refers to a member of the family consisting of fluorine, chlorine, bromine or iodine. The term alkanoyl refers to the radical formed by removal of the hydroxyl function from an alkanoic acid. Examples of alkanoyl groups are formyl, acetyl, propionyl, 2,2 dimethylacetyl, hexanoyl, octanoyl, and the like.The term lower1 as applied to any of the aforementioned groups refers to a group having a carbon skeleton containing up to and including 6 carbon atoms. In the formulas presented herein the various substituents are illustrated as joined to the labdane nucleus by one of two notations a solid line indicating a substituent which is in the orientation i.e., above the plane of the molecule and a broken line indicating a substituent which is in the orientation i.e., below the plane of the molecule . The formulas have all been drawn to show the compounds in their absolute stereochemical configuration. Inasmuch as the starting materials having a labdane nucleus are naturally occurring or are derived from naturally occurring materials, they, as well as the final products, have a labdane nucleus existing in the single absolute configuration depicted herein.The processes of the present invention, however, are intended to apply as well to the synthesis of labdanes of the racemic series. In addition to the optical centers of the labdane nucleus, the substituents thereon may also contain chiral centers contributing to the optical properties of the compounds of the present invention and providing a means for the resolution thereof by conventional methods, for example, by the use of optically active acids. A wavy line E connecting a group to a chiral center indicates that the stereochemistry of the center is unknown, i.e., the group may exist in any of the possible orientations. The present invention comprehends all optical isomers and reacemic forms of the compounds of the present invention where such compounds have chiral centers in addition to those of the labdane nucleus. The novel labdanes of the present invention are synthesized by the processes illustrated in Reaction Scheme A and B. To prepare a basic labdane 3 wherein R7 is alkanoyl and R19 and R2 are as hereinbeforedescribed, a , dihydroxylabdane 2 wherein R7 is alkanoyl is condensed with a formamide dialkylacetal of formula 16 EMI5.1 wherein R21 is alkyl and R19 and R2 are as hereinbeforedescribed to provide a basic labdane 3. The condensation is preferably performed in the absence of an added solvent, excess formamide dialkylacetal serving both as the reactant and solvent. A dipolar aprotic solvent such as dimethylformamide, dimethylacetamide, hexamethylphosphoramide or dimethylsulfoxide may be employed, however, as the reaction medium. The temperature at which the condensation is conducted is not critical. A condensation temperature within the range of about 250 to about 1BBOC is generally employed to assure a reasonable rate of reaction. A temperature of about 450 to about 65 0C is preferred. To prepare a labdane of formula 4 wherein R19 and R2g are as before and R6 is alkanoyl, a alkanoyloxy 6 hydroxy labdane 3 is rearranged to a alkanoyloxy hydroxylabdane 4. The rearrangement Is conveniently performed in an aqueous alkanol containing an alkali metal hydroxide. Among alkanols there may be mentioned methanol, ethanol, 1 and 2 propanol and t butanol.Methanol is preferred. Among alkali metal hydroxides there may be included lithium, sodium and potassium hydroxide. Sodium hydroxide is preferred. While the rearrangement is preferably performed at about ambient temperature, it may be conducted at a reduced temperature within the range of about 0 to about 25 C, or at an elevated temperature of about 250 to 350C. The rearrangement may preferably be effected, for example, by treating 3 with lithium 1,1,1,3,3,3 hexamethyldisilazide in an ethereal solvent such as tetrahydrofuran, dioxane, 1,2 dimethoxyethane or bis 2 methoxyethyl ether at a reduced temperature of about BOC. To furnish a basic labdane formula 5 wherein R19 and R2 are as above, a 6 alkanoyloxy hydroxylabdane 4 is hydrolyzed to the 6 , g dihydroxylabdane 5. The hydrolysis is carried out in an aqueous alkanol such as aqueous methanol, ethanol, 1 or 2 propanol or t butanol, aqueous methanol being preferred, containing an alkali carbonate such as lithium, sodium or potassium carbonate, potassium carbonate being prefered, at a hydrolysis temperature within the range of about 10 to about 75 C, a hydrolysis temperature of about 250C being preferred. A 6 dihydroxylabdane of formula 5 may also be prepared by hydrolysis of a g alkanoyloxy hydroxylabdane of formula 3 by means of the hereinbeforedescribed processes for the conversion of 4 to 5. To introduce a , sulfita or f carbonate function into the basic labdane nucleus, i.e., to prepare a compound of formula Z wherein X is SO or CO, respectively, a dihydroxylabdane of formula 5 is treated with a compound of formula 11. HalZHal 11 wherein Hal is bromo or chloro, preferably chloro, and Z isSO or CO in the presence of an organic base such as trimethyl or triethylamine, pyridine, lutidine or collidine at a reduced temperature within the range of about 250 to about 25 0C. The preferred organic base is pyridine and the preferred reaction temperature is about BOC. To elaborate, a basic labdane characterized by the presence of aminoacyloxy and aminoacetal moieties, a hydroxylabdane 5 is esterified with an aminoacid of formula 12. R11R12NCHR1 3CO2H 12 wherein R11, R12 and R13 are as hereinbeforedescribed. The esterification is conveniently effected in a halocarbon such as dichloromethane or tirchioromethane in the presence of a carbodiimide such as dicyclohexylcarbodiimide and a catalyst such as 4 N,N dimethylamino pyridine at a reaction temperature within the range of about 80 to about 580C. Dichloromethane and dicyclohexylcarbodiimide are the preferred halocarbon and carbodiimide, respectively. A reaction temperature of about 250C is also preferred. A hydrohalide of the aminoacid, for example, an aminoacid hydrochloride, may be employed in the process for the esterification of a hydroxylabdane. To construct a basic labdane characterized by an aminoacyloxy function at the 3 position and a free hydroxy group at the position of the labdane nucleus, i.e., to synthesize a compound of formula 9 wherein R11, R12 and R13 are as hereinbeforedefined, alkanoyloxylabdane 2 is hydrolyzed under conventional conditions utilizing an alkali metal carbonate such as sodium carbonate in an aqueous alkanol such as methanol at a reaction temperature of about 250C to the known 1 alpha ,6ss,2ss,9 alpha tetrahydroxy labdane 8 which is estetified with a compound of the formula 12. R11R12NCHR13CO2H 12 wherein R11, R12 and R13 are as hereinbeforedefined under reaction conditions substantially similar to those employed for the conversion of 5 to 6 described above. Alternatively, basic labdanes of formula 2 may be prepared by hydrolysis of the amincacetal moiety of labdanes of formula 6.The hydrolysis may be accomplished by treating an aminoacetal of formula 6 with an alkanoic acid such as acetic or propanoic acid, preferably acetic acid, in an aqueous alkanol such as methanol, ethanol or 1 or 2 propanol, preferably aqueous methanol, at a temperature within the range of about 9 to 50 C, preferably at a temperature of about 25 0C. Basic labdanes of formula q are also prepared by desilylation of a compound of formula 15. The rempval of the silyl group is achieved by, for example treating the 1 alpha sily oxylabdane S with aqueous hydrogen fluoride in acetonitrile at a temperature of about 25 0C. To gain entry into the labdane system h aving a basic moiety at the 2ss position and a silyloxy group at the 1 alpha position, i.e., to provide basic labdanes of formula 15 wherein B3, R4, R5, R11,R12, and R13 are as above, a 2ss alkanoyloxy 2 alpha hydroxylabdane 2 is silylated to a 2ss alkanoyloxy 1 alpha silyloxylabdane 13 which is hydrolyzed to a 1ss hydroxy 1 alpha silyloxylabdane 14 and converted to a basic labdane 15. To effect the silylation, one treats a 1 alpha hydroxylabdane 2 with a N trialkylsilyl N alkyltrifloroacetamide of formula 16 R3R4R5S,i NR23COCCZ3 16 wherein R3, R4 and R5 are as above and Rz3 is alkyl, preferably a trifluoroacetamide wherein R23 is alkyl1 most preferablyN t butoxydimethylsilyl N methyltrifluoroacetamide, in a dipolar aprotic solvent such as dinethylformamide, dimethylacetamide, hexamethylphosphoramide or dimethylsulfoxide, preferably dimethylformamide, at a temperature within the range of about 0 to 75 C, preferably at a reaction temperature of about 250C, to afford a compound of formula 13. The hydrolysis is accomplished by treating a alkanoyloxy 1 alpha trialkylsilyloxylabdane 13 with an alkali metal carbonate in an aqueous alkanol. Included among alkali metal carbonates are lithium, sodium and potassium carbonate. Included among alkanols are methanol, ethanol, 1 and 2 propanol and t butanol. Potassium carbonate and methanol are the preferred alkali metal carbonate and alkanol. While the reaction temperature is not narrowly critical, it is preferable to perform the hydrolysis at an elevated temperature within the range of about 60 to about 100 C. A hydrolysis temperature of about 8BOC is most preferred. The introduction of the basic moiety at the 2ss position of the labdane nucleus, i.e., the conversion of a 2ss hydroxylabdane 14 to a i aminoalkylcarbonyloxylabdane 15 is achieved by processes substantially similar to those employed for the conversion of g hydroxylabdane 5 to i aminoalkylcarbonyloxylabdane 6. For example, one treats a ahydroxylabdane 14 with an aminoacid 12, free or as the hydrohalide salt, in a halocarbon solvent such as dichloromethane in the presence of a catalyst such as 4 dimethylaminopyridine and a carbodiimide such as dicyclohexylcarbodiimide at about ambient temperature ca.250C to provide a compound of formula 15. To synthesize a labdane having a 6 ffi sulfite or carbonate function and a 1 alpha hydroxy group, i.e., a compound of formula 17 wherein X is SO or CO, a g silyloxylabdane of formula 14 is converted to a 1 alpha silyloxylabdane 6ss,1ss sulfite or carbonate of formula 16 by processes substantially similar to those employed for the conversion of a compound of formula 5 to a compound of formula 7 followed by desilylation by the process described above for the transformation of a 1 alpha silyloxylabdane 15 to a 4 hydroxylabdane 9. The labdane starting materials for the processes of the present invention, i.e., labdanes of formula 3 wherein R7 is hydrogen or a group of the formula R8Ct wherein R8 is as herein beforedescribed, are described in U.S. patent 4,134,986, issuedJanuary 16, 1979 to B. S. Bajwa, et al., or may be prepared from compounds disclosed therein by conventional processes. The labdanes of the present invention are useful in the treatment of elevated intraocular pressure by virtue of their ability to reduce intraocular pressure as determined by the method described by J. Caprioli, et al., Invest. Ophthalmol. Vis.Sci., 25, 268 1984 . The results of the determination expressed as percent decrease of outflow pressure is presented in theTable. TABLE DECREASE IN OUT COMPOUND CONCENTRATION FLOW PRESSURE 2ss N,N diethylaminoacetoxy 8,13 epoxy 1 alpha ,6ss,9 alpha trihydroxylabd 14 en 11 one 1,9dimethylformamide acetal 2 36 N acetylamino acetoxy 8,13 epoxy 6ss,2 alpha ,trihydroxy labd 14 en 11 one 2 59 that N t butoxy carbonyl aminolpro panoyloxy 8,13 epoxy 1 alpha ,6ss,2 alpha trihydroxylabd 14 en il one 1 43 2ss N,N diethylaminoacetoxy 8,13 epoxy 1 alpha ,6ss,2 alpha trihydroxy labd 14 an 11 one 2 27 N,N dimethyl aminoacetoxy 8,13 epoxy 1 alpha ,6ss,9 alpha trihydroxy labd 14 en ll one 2 8,13 epoxy trihydroxy 2 tetrahydrofuranoyl oxy labd 14 en ll one 2 51 2ss acetoxy 8,13 epoxy 2 alpha 6ss,2 alpha trihydroxy labd 14 en 11 one 1.0 51 e.l 23 Intraocular pressure reduction is achieved when the present labdanes are administered to a subject requiring such treatment as an effective topical dose of a B.B1 to 3.0 solution or suspension. A particularly effective amount is about 3 drops of a 1 preparation per day. It is to be understood, however, that for any particular subject, specific dosage regimens should be adjusted according to the individual need and the professional judgment of the person administering or supervising the administration of the aforesaid compound.It is to be further understood that the dosages set forth herein are exemplary only and that they do not, to any extent, limit the scope or practice of the invention. Compounds of the present invention are also useful for the treatment of hypertension, congestive heart failure, bronchial asthma and psoriasis. Compounds of the present invention include 1 1 alpha acetoxy 2ss N,N dimethylaminoacetoxy 8,13 epoxy 6g, 8 dihydroxylabd 14 en 11 one. 2 2ss N,N dimethylaminoacetoxy 8,13 epoxy 6ss hydroxylabd 14 en 11 one 1 alpha ,2 alpha sulfit. 3 2ss N,N dimethylaminoacetoxy 8,13 epoxy 1 alpha ,6ss,2 alpha tri hydroxylabd 14 en 11 one 1,9 pyrrolidineformamide acetal. 4 6 alpha N t butoxycarbonyl aminocetoxyl 8,13 epoxy 1 alpha , 2 alpha 9 alpha trihydroxylabd 14 en 11 one. 5 8,13 epoxy 1ss formyloxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en plane 1,9 dimethylformamide acetal. 6 2ss N, N dimethylaminoacetoxy 8,13 epoxy 1 alpha formyloxy 6ss, 9 alpha dihydroxylabd 14 en 11 one. 7 7ss N, N dimethylaminoacetoxy 8,13 epoxy 6ss hydroxy labd 14 en lI one , carbonate. 8 7ss N, N dimethylaminoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en 11 one 1,9 piperidineformamide acetal. 9 7ss N, N dimethylaminoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en 11 one 1,9 morpholineformamide acetal. 10 7ss N, N dimethylaminoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en 11 one 1,9 thiomopholineformamide acetal. 11 8,13 epoxy 1 alpha , 9 alpha dihydroxylabd 14 en one 1,9 dimethyl formamide acetal 6ss, 7ss carbonate. 12 7ss aminoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en ll one. 13 7ss 1 piperidinoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha tri hydroxylabd 14 en 11 one. 14 7ss 1 pyrrolidinoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha tri hydroxylabd 14 en ll one. 15 7ss 4 morpholinoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha tri hydroxylabd 14 en 11 one. 16 7 4 thiomopholinoacetoxy 8,13 epoxy 4,6j,4 tri hydroxylabd 14 en 11 one. 17 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxy 2ss 2 aminopropiony loxy labd 14 en 11 one. 18 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxy 2ss 2 amino 3 phppenyl propionyloxy labd 14 en 11 one. Effective amounts of the compounds of the present invention may be administered to a subject by any one of various methods, for example, orally as in capsules or tablets, parenterally in the form of sterile solutions or suspensions, in some cases intravenously in the form of sterile solutions, or suspensions, and topically in the form of solutions, suspension or ointments, and by aerosol spray. The labdanes of the present invention, while effective themselves, may be formulated and administered in the form of their pharmaceutically acceptable addition salts for purposes of increased solubility and the like. Preferred pharmaceutically acceptable addition salts include salts of mineral acids, for example, hydrochloric acid, sulfuric acid, nitric acid and the like, salts of monobasic carboxylic acids such as, for example, acetic acid, propionic acid and the like, salts of dibasic carboxylic acids such as, for example, maleic acid, fumaric acid and the like, and salts of tribasic carboxylic acids such as, for example, citric acid and the like. Effective quantities of the compounds of the invention may be administered orally, for example, with an inert diluent or with an edible carrier. They may be enclosed in gelatin capsules or compressed into tablets. For the purpose of oral therapeutic administratipn, the aforesiad compounds may be incorporated with excipients and used in the form of tablets, troches, capsules, elixirs, suspensions, syrups, wafers, chewing gums and the like.These preparations should contain at least .58 of active compound, but may be varied depending upon the particular form and may conveniently be between 4 to about 7 of the weight of the unit. The amount of active compound in such composition is such that a suitable dosage will be obtained. Preferred compositions and preparations according to the present invention are prepared so that an oral dosage unit form contains between .1 3 milligrams of the active compound. The tablets, pills, capsules, troches and the like may also contain the following ingredients a binder such as microcrystalline cellulose, gum tragancanth or gelatin an excipient such as starch or lactose, a disintegrating agent such as alginic acid, corn starch and the like a lubricant such as magnesium stearate a glidant such as colloidal silicon dioxide and a sweetening agent such as sucrose or saccharin or a flavoring agent such as peppermint, methyl salicylate, or orange flavoring may be added. When the dosage unit form is a capsule, it may contain, in addition to materials of the above type, a liquid carrier such as a fatty oil. Other dosage unit forms may contain other various materials which modify the physical form of the dosage unit, for example, as coatings. Thus, tablets or pills may be coated with sugar, shellac, or other enteric coating agents.A syrup may contain, in addition to the active compounds, sucrose as a sweetening agent and certain preservatives, dyes and colorings and flavors. Materials used in preparing these various compositions should be pharmaceutically pure and non toxic in the amounts used For the purpose of parenteral or topical therapeutic administeration, the active compounds of the invention may be incorporated into a solution, suspension, ointment or cream.These preparations should contain at least B,B1 of active compound, but may be varied between 8.5 and about 5t of the weight thereof. The amount of active compounds in such compositions is such that a suitable dosage will be obtained.Preferred compositions and preparations according to the present invention are prepared so that a parenteral dosage unlit contains between 6.g1 to 1 milligrams of active compound. The solutions or suspensions for topical or parenteral administration may also include the following components a sterile diluent such as water for injection, saline solution, fixed oils, polyethylene glycols, glycerine, proplyene glycol or other synthetic solvents antibacterial agents such as benzyl alcohol or methyl parabens antioxidants such as ascorbic acid or sodium bisulfite chelating agents such as ethylenediaminetetraacetic acid buffers such as acetates, citrates or phosphates and agents for the adjustment of tonicity such as sodium chloride or dextrose, The parenteral preparation can be enclosed in ampules or disposable syringes the topical preparation may be enclosed in multiple dose vials or dropping bottles, made of glass or plastic. The following examples are for illustrative purposes only and are not to be construed as limiting the invention. All temperatures are given in degrees Centigrade. EXAMPLE 1 2ss Acetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en 11 one 1,9 dimethylformamide acetal 2ss Acetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en 11 one 10 g mg was dissolved in 1 ml of dimethylformamide dimethyl acetal. The mixture was stirred 1 hr at room temperature and overnight at 550 under nitrogen. The mixture was dissolved in ether, washed with water, dried over anhydrous sodium sulfate, filtered and concentrated to an oil. The oil was dissolved in a minimum volume of dichloromethane and chromatographed using 18 g of silica gel 238 488 mesh . Eluent 8 x 3 ml of dichloromethane, 8 x 3 ml of 3 methanol dichloromethane and 8 x 3 ml of 5 methanol dichloromethane.Evaporation of the solvent from appropriate fractions followed by drying at 68 1 mm provided 98 mg 79.1 of product as an oil. ANALYSIS Calculated for C25H39N07 64.49 C 8.44 H 3.01 NFound 64.69 C 8.25 H 3.89 N EXAMPLE 2 6ss Acetoxy 8,13 epoxy 1 alpha , 7ss, 9 alpha trihydroxylabd 14 en 11 one 1,9 dimethylformamide acetal A solution of 288 mg of 7ss acetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en ll one in 2 ml of dimethylformamide dimethylacetal was stirred at 350 overnight, under nitrogen, and allowed to cool to room temperature. To the mixture was added 18 ml of an 28 aqueous methanolic solution of sodium hydroxide.The mixture was stirred overnight at room temperature. The mixture was diluted with ethyl acetate, washed twice with water, saturated sodium chloride solution and dried over anhydrous sodium sulfate. Filtration followed by evaportion of solvent provided an oil. The material was flash chromatographed using 26 g of silica gel 238 488 mesh eluent 58 x 15 ml of 38 78 ethyl acetate bexane Evaporation of the appropriate fractions followed by drying at 880 1 mm provided 81 mg 35.6 ofproduct, mp 173 175 . ANALYSIS Calculated for C25H39N07 64.49 C 3.44 H 3.1tN Found 64.59 C 8.56 H 2.86 N EXAMPLE 3 8,13 Epoxy 1 alpha , 6ss, 7ss, 9 alpha tetrahydroxylabd 14 en 11 one 1,9 dimethylformamide acetal A solution of 225 mg of 7ss acetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha tetranydroxylabd 14 en 11 one 1,9 dlmethylformamide acetal was stirred at room temperature under nitrogen for 5 hrs in 5 ml of saturated potassium carbonate solution in 20 aqueous methanol.The solution was diluted with water and extracted twice with ether. The ether extracts were washed twice with water and dried over anhydrous sodium sulfate. Filtration followed by evaporation of the solvent provided an oil, which crystallized on standing. The crystals were dried at 1130 1 mm to yield 192 mg 88.5t of product, mp 136 144 . ANALYSIS Calculated for C23H37NO6 65.22 C 8.81 H 3.31 NFound 65.18 C 8.76 H 3.25 N EXAMPLE 4 8,13 Epoxy 1 alpha , 9 alpha dihydroxylabd 14 en 11 one 1 alpha , 9 alpha dimethyl formamide acetal 6ss, 7ss sulfite To a stirred solution of 288 mg of 8,13 epoxy 1 alpha , 6ss, 7ss, 9 alpha tetrahydroxylabd 14 en 11 one 1 alpha , 9 alpha dimethylformamide acetal in 2 ml of dry pyridine was added slowly, dropwise, a solution of 8.2 ml of thionyl chloride in 4 ml of dry pyridine. The mixture was stirred 15 min at g0, poured into water, and extracted twice with ether. The extracts were washed twice with water, dried over anhydrous sodium sulfate and filtered. Concentration provided an oil.The material was dissolved in a minimum volume of 25 ethyl acetate hexane and purified by flask chromatography on 25 g of silica gel 230 400 mesh eluent 20 x 15 ml of 25 ethyl acetate hexane . Concentration of the appropriate fractions followed by drying at 40 1 mm provided 0.148 g 66.7 of product, mp 157 1620. ANALYSIS Calculated for C23H35N07S 58.82 C 7.51 H 2.98 N Found 58.72 C 7.51 H 2.56 N EXAMPLE 5 N t Butoxycarbonyl aminoacetoxy 8,13 epoxy 1 alpha ,6ss,9 alpha tri hydroxylabd 14 en ll one To a mixture of 188 mg of 8,13 epoxy 1 alpha ,6ss,7ss,9 alpha tetra hydroxylabd 14 en ll one, 34.1 mg of 4 dimethylaminopyridine and 47.6 mg of N t butoxycarbonylglycine dissolved in 5 ml of dichloromethane was added a solution of 61.6 mg of dicyclohexylcarbodiimide dissolved in 2 ml of dichloromethane. The mixture was stirred under nitrogen for 4 hr. The mixture was filtered and the filtrate was evaporated to dryness. The residue was purified by flash chromatography on silica gel in hexane ethyl acetate 3 1 .The appropriate fractions were combined and evaporated to dryness under vacuum. The residue was crystallized from hexane, filtered and dried yielding 187.3 mg 75.2 of product, mp 94l880. ANALYSIS Calculated for C27H43NOg 61.68 C 8.26 H 2.66 NFound 62.12 C 8.58tH 2.57 N EXAMPLE 6 7ss N, N Diethylaminoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en 11 one 1 alpha , 9 alpha dimethylformamide acetal To a mixture of 158 mg of 8,13 epoxy 1 alpha , 6ss, 7ss, 9 alpha tetra hydroxylabd 14 en lI one dimethylformamide acetal, 59.4 mg of diethylglycine hydrochloride, 44.6 mg of 4 N,N dimethylamino pyridine in 6 ml of dichloromethane was added g. mg of dicyclohexylcarbodiimide dissolved in 3 ml of dichloromethane.The mixture was stirred under nitrogen at ambient temperature overnight. The mixture was filtered and evaporated to dryness under vacuum. The residue was flash chromatographed in hexane ethyl acetate 1 1 . The appropriate fractions were combined and evaporated to dryness to yield 138.3 mg 72.8 of product, mp 129 1330, ANALYSIS calculated for C29H48N2O7 64.898C 9.83 H 5.22 N Found 65.17 C 8.87 H 5.46 N EXAMPLE 7 7ss Acetoxy 1 alpha t butyldimethylsilyloxy 6ss, 9 alpha dihydroxy 8l3 epoxylabd l4 en ll one To a solution of 1.60 g of 7ss acetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en 11 one in 5 ml of dimethylformamide was added, dropwise, 610 ul of N t butyldimethylsilyl N methyltrifluoroacetamide, and the reaction mixture was stirred for 1 hr. The mixture was allowed to stand at room temperature overnight, and was then diluted with 5 ml of one half saturated brine and extracted with diethyl ether. The combined extracts were dried over anhydrous sodium sulfate, filtered and the filtrates were evaporated. The residue was flash chromatographed on a silica gel column using ethyl acetate hexane 1 3 as the eluent. Evaporation of the appropriate fractions gave 1.24g 97.2 of product. EXAMPLE 8 t Butyldimethylsilyloxy 8,13 epoxy 1 alpha , 6ss, 7ss, 9 alpha trihydroxylabd 14 en ll one A solution of 1.24 g of 0 acetoxy F t butyldimethyl zilyloxy 8,13 epoxy 1 alpha , 6ss, 9 alpha dihydroxylabd 14 en 11 one, 4 ml of saturated potassium carbonate solution and 16 ml of methanol was heated at 8BO for 1 hr. The reaction mixture was cooled, diluted with saturated sodium chloride solution, and extracted with ether. The combined ether extracts were dried over anhydrous potassium carbonate, filtered, and the filtrate was evaporated.The residue was flash chromatographed on silica gel column using ethyl acetate hexane 1 3 as the eluent. Evaporation of the appropriate fractions provided 646 mg 56.5 of product. EXAMPLE 9 1ss N, N Dimethylaminoacetoxy 8,13 epoxy , 9 alpha dihydroxy 1 alpha t butyldimethylsilyloxy labd 14 en 11 one hydrochloride 8,13 epoxy 6ss,7ss, 9 alpha trihydroxy 1 alpha t butyldimethylsily loxy labd 14 en ll one l mg was dissolved in 4 ml of dichloromethane with 29. mg of dimethylglycine hydrochloride and 26. mg of 4 dimethylaminopyridine. To the above mixture was added 48 mg of N,N dicyclohexylcarbodiimide dissolved in 1 ml of dichloromethane. The mixture was stirred at ambient temperature for 18 hr. The mixture was filtered through a cotton plug and the filtrate was evaporated to dryness. The residue was suspended in ether, filtered and evaporated to dryness.The residue was flash chromatographed on silica gel in hexane ethyl acetate methanol 10 10 1 . The appropriate fractions were combined and evaporated to dryness to provide 87.8 mg 74.7 of product. The product was dissolved in ether and the hydrochloride precipitated, mp 227 228 .ANALYSIS Calculated for C38H54ClNO7Si 59.61 C 9.2 H 2.32 N Found 60.06 C 9.22 H 2.19 N Example 10 1ss N ,N Dimethylaminoacetoxy 8,13 epoxy 6ss, 9 alpha dihydroxy 1 alpha t butyldimethylsilyloxy labd 14 en 11 one hydrochloride 8,13 Epoxy 6ss, 7ss, 9 alpha trihydroxy 1 alpha t butyldimethyl silyloxy labd l4 en ll one 58 mg was combined with 17.4 mg ofN,N diethylglycine hydrochloride and 13.1 mg of 4 N,N dimethyl amino pyridine in 2 ml of dry dichloromethane. Dicylohexylcarbodiimide 24 mg dissolved in 1 ml of dichloromethane was added to the above mixture in a sealed tube. The mixture was allowed to stand at ambient temperature overnight. The dicyclohexylurca was filtered off.After the filtrate was evaporated to dryness, the residue was suspended in ethyl acetate and filtered. The filtrate was flash chromatographed on silica gel in hexane ethyl acetate 3 1 . The appropriate fractions were combined and evaporated to dryness under vacuum. The residue was dissolved in ether, fror which the product as the hydrochloride was precipitated, and yielded 32.7 mg of product, mp 200 210 .ANALYSIS Calculated for C32H58ClNO7Si 60.77 C 9.26 H 2.21 NFound 60.88 C 9 .6S H 2.33 N EXAMPLE 11 N, N Dimethylaminoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxy labd I4 en ll one hydrochloride N, N Dimethylaminoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihy droxylabd l4 en ll one dimethylformamide acetal 103.1 mg was dissolved in a mixture of 1.4 ml of methanol and 1.4 ml of 86 acetic acid. The mixture was stirred at ambient temperature for 3 days after which it was evaporated to dryness. The residue was dissolved in ether and extracted several times with 5 sodium bicarbonate solution. The organic phase was dried over anhydrous sodium sulfate, filtered and evaporated to dryness.The residue was flash chromatographed on silica gel packed in hexane ethyl acetate methanone l lg l . The appropriate fractions evaporated to dryness. The residue was dissolved in ether and treated with ethereal hydrogen chloride to afford 28 mg 3.5z of product, mp 255 260 dec .ANALYSIS Calculated for C24H40ClNO7 58.81 C 8.24 H 2.86 NFound 58.77 C 8.19 H 2.73 N EXAMPLE 12 7ss N, N Diethylaminoacetoxy N, N Dimethylaminoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en 1l one hydrochloride 74 N,N diethylaminoacetoxy 8,13 epoxy H tri hydroxylabd 14 en 1l one 1 ,9 dimethylformamide acetal 84.1 mg was dissolved in 2 ml of a mixture of methanol acetic acid water 10 8 2 and allowed to stand overnight under nitrogen at ambient temperature. The mixture was basified with saturated aqueous sodium bicarbonate solution. The product was extracted into dichloromethane, dried over anhydrous sodium sulfate, filtered and evaporated. The residue was dissolved in ether and treated with ethereal hydrogen chloride.The ether suspension was evaporated and the residue was resuspended in ether. The solid was filtered and dried under vacuum at 860 for 1 hr to yield 42.2 mg 52.0 of product, mp 149 156 dec .ANALYSIS Calculated for C26H43ClNO7 60.26 C 8.58 H 2.70 NFound 59.66 C 8.52 H 3.11 N EXAMPLE 13 7ss Methoxyacetoxy 8,13 epoxy 1 alpha ,6ss,9 alpha trihydroxylabd 14 en ll one 8,13 Epoxy 1 alpha ,6ss,7ss,9 alpha tetrahydroxylabd 14 en 11 one 100 mg was dissolved in 5 ml of dichloromethane together with 34.2 mg of 4 dimethylaminopyridine and 24.5 mg of methoxyacetic acid. To the above solution was added 61.7 mg of dicyclohexylcarbodiimide dissolved in 2 ml of dichloromethane, and the mixture was stirred overnight under an atmosphere of nitrogen.The mixture was filtered, evaporated to dryness and loaded onto a flash silica gel column packed in dichloromethane methanol le 9.2 . The appropriate fractions were combined and evaporated to dryness. Trituration of the residue with hexane provided 49.5 mg 41.48 of product, mp 164 170 .ANALYSIS Calculated for C23R3608 62.7 C 8.25 HFound 62.51 C 8.22 H EXAMPLE 14 2ss 2 N t Butoxycarbonyl aminopropanoyloxy 8,13 epoxy 1 alpha ,6ss, 9 alpha trihydroxylabd 14 en 11 one 8,13 Epoxy 1 alpha ,6ss,7ss,9 alpha tetrahydroxylabd 14 en 11 one 100 mg was stirred with 34.2 mg of 4 dimethylaminopyridine and 51.4 mg of N t butoxycarbonyl L alanine in 5 ml of dichloromethane. flicyclohexylcarbodiimide 61.7 mg dissolved in 2 ml of dichloromethane was added to the mixture and was allowed to stand overnight under nitrogen at ambient temperature. The mixture was diluted with ether, filtered and evaporated to dryness. The residue was flash chromatographed on silica gel packed in hexane ethyl acetate 3 1 . The appropriate fractions were combined and evaporated to dryness. Trituration of the residue with hexane provided 74.1 mg 50.6 of product, mp 117 122 dec .ANALYSIS Calculated for C28H45NO9 62.31 C 8.42 H 2.59 NFound 62.2 C 8.39 H 2.998N EXAMPLE 15 N Acetylaminoacetoxy 8,13 epoxy 1 alpha ,6ss,9 alpha trihydroxylabd14 en li one 8,13 Epoxy 1 alpha ,6ss,7ss,9 alpha tetrahydroxylabd 14 en 11 one 100 mg was stirred with 34.2 mg of 4 dimethylaminopyridine and 31.8 mg of N acetylglycine in 5 ml of dichloromethane. Dicyclohexyl carbodiimide 61.7 mg dissolved in 2 ml of dichloromethane was added to the solution and the resultant mixture was stirred under nitrogen at ambient temperature overnight. The mixture was filtered and evaporated to dryness.The residue was flash chromatographed on silica gel packed in hexane ethyl acetate 1 1 . The appropriate fractions were combined and evaporated to dryness. The residue was triturated with cyclohexane affording 26.6 mg 21.9 of product, mp 106 110 .ANALYSIS Calculated for C24H37NO8 61.64 C 7.99 H 2.99 NFound 62.01 C 8.27 H 2.60 N EXAMPLE 16 4 Morpholinoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en ll one hydrochloride hydrate 8,13 Epoxy 1 alpha ., 6ss, 7ss, 9 alpha tetrahydroxylabd 14 en 11 one 100 mg was dissolved in 5 ml of dichloromethane and stirred with 34.2 mg of 4 N,N dimethylaminopyridine and 49.3 mg of 4 morpholinoNacetic acid hydrochloride. Dicyclohexyl carbodiimide 61.7 mg in 2 ml of dichloromethane was added to the mixture and was stirred under nitrogen overnight at ambient temperature. The mixture was diluted with ether and filtered.The filtrate was evaporated. The residue was flash chromatographed on silica gel in hexane ethyl acetate 1 1 and eluted with hexane ethyl acetate methanol 10 10 1 . The appropriate fractions were combined and evaporated. The residue was dissolved in ether and treated with ethereal hydrogen chloride to yield 55.5 mg 38.4 of product, mp 165 175 dec .ANALYSIS Calculated for C26H44C1NO9 56.76 C 8.08 H 2.54 NFound 57.91 C 7.69 H 2.77 N EXAMPLE 17 7ss N 2 Nitrophenylsulfenyl aminoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en 11 one 8,13 epoxy 1 alpha , 6ss,7ss, 9 alpha trihydroxylabd 14 en 11 one 325 mg 361.7 mg of N 2 nitrophenylsulfenyl glycine dicyclohexylammonium salt and 149 mg of 4 N,N dimethylaminopyridine hydrochloride were suspended in 25 ml of dichloromethane. After dissolution occurred, a solution of 273.3 mg of dicyclohexy carbodiimide in 5 ml of dichloromethane was added. The mixture was allowed to stand at ambient temperature overnight.The mixture was filtered and the filtrate was evaporated to dryness.The residue was flash chromatographed on silica gel in dichloro methane methanol 19 9.2 . The appropriate fractions were combined and evaporated to dryness. The residue was crystallized from hexane ether yielding, in two crops, 153.5 mg 30.1 of product, mp 104 dec. ANALYSIS Calculated for C28H38N209S 58.11 C 6 62 H 4.84 NFound 57.63 C 6.61 H 5.41 N EXAMPLE 18 8,13 Epoxy 9 alpha hydroxy 1 alpha t butyldimethylsilyloxy labd 14 en 11 one 6 alpha ,7ss sulfite 8,13 Epoxy 6ss,7ss,9 alpha trihydroxy 1 alpha t butyldimethyl silyloxy labd 14 en ll one 200 mg was dissolved in 2. ml of pyridine together with 286 ml of thionyl chloride at 50. After 0.5 hr, the mixture was poured into water and extracted with ethyl acetate. The organic extracts were combined, dried over anhydrous sodium sulfate filtered and evaporated to dryness under vacuum The residue was flash chromatographed silica gel, hexane ethyl acetate 3 1 . The appropriate fractions were combined and evaporated to dryness to give 122.2 mg of product, mp 107 109 .ANALYSIS Calculated for C26H44O7SSi 59.05 C 8.40 HFound 58.74 C 8.24 H EXAMPLE 19 8,13 epoxy 1 alpha ,9 alpha dihydroxylabd 14 en 11 one 6ss, 7ss sulfite 8,13 Epoxy 9 alpha hydroxy 1 alpha t butyldimethylsilyloxy labd 14 en il one 6ss,7ss sulfite 487.S mg was dissolved in 25 ml of acetonitrile and 40 aqueous hydrofluoric acid 95 5 and stirred at ambient temperature for six hrs. The mixture was basified with saturated aqueous sodium bicarbonate solution and the layers were separated. The aqueous phase was extracted with ethyl acetate which was then combined with the organic phase. The combined organic phases were dried over anhydrous sodium sulfate, filtered and evaporated to dryness.The residue was flash chromatographed on silica gel in hexane ethyl acetate 3 1 . The appropriate fractions were combined and evaporated to dryness to provide 28.7 mg 54.6 of product, mp 186 193 dec .ANALYSIS Calculated for C2H3O7S 57.95 C 7.31 HFound 58.27 C 7.21 H EXAMPLE 20 8,13 Epoxy 1 alpha ,6ss,9 alpha trihydroxy 2ss 2 2 nitrophenylsulfenyl amino propionyl labd 14 en 11 one 8,13 Epoxy 1 alpha ,6ss,7ss,9 alpha tetrahydroxylad 14 en 11 one was dissolved in 50 ml of dry dichloromethane along with 863 mg of 2 2 nitrophenylsulfenylamino propionic acid, dicyclohexylammonium salt, 323 mg of 4 dimethylaminopyridine hydrochloride and 547 mg of dicyclohexylcarbodiimide. The mixture was stirred at ambient temperature under nitrogen overnight, after which it was diluted with ether and filtered.The filtrate was evaporated and the residue was dissolved in dichloromethane and flash chromatographed on silica gel packed with dichloromethane methanol 10. 0.2 . The appropriate fractions were combined and evaporated. The residue was crystallized from hexane ether to give 627.6 mg 53 of product, mp 209 216 ANALYSIS Calculated for C29H,41N209S 58.76 C 6.82 H 4.72 NFound 58.60 C 7.6 H 4.74 N EXAMPLE 21 8,13 Epoxy 1 alpha ,6ss,9 alpha trihydroxy 7ss 2 tetrahydrofuranoyloxy labd 14 en ll one 8,13 Epoxy 1 alpha ,6ss,7ss,9 alpha tetrahydroxylabd 14 en 11 one 500 mg was dissolved in 58 ml of dry dichloromethane along with 157.6 mg of 2 tetrahydrofuroic acid, 174 mg of 4 dimethylaminopyridine and 420 mg of dicyclohexylcarbodiimide. The mixture was stirred at ambient temperature under nitrogen overnight. The mixture was diluted with an equal volume of ether and was filtered. The filtrate was evaporated and the residue was flash chromatographed on silica gel in dichloromethane methanol 10 0.2 . The appropriate fractions were combined, evaporated, and the residue was crystallized from cyclohexane to give 100.5 mg 28.4 of product, mp 162 165 .ANALYSIS Calculated for C25H38O8 64.34 C 8.23 H Found 64.25 C 8.14tH EXAMPLE 22 2ss 1 Piperidinoacetoxy 8,13 epoxy 1 alpha ,6ss,9 alpha trihydroxy and 14en 11 one 1,9 dimethylformamide acetal 8,13 Epoxy 1 alpha ,6ss,7ss,9 alpha tetrahydroxylabd 14 en 11 one 1,9 dimethylformamide acetal 750 mg was dissolved in 58 ml of dichloromethane with 318.3 mg of 2 1 piperidino acetic acid hydrochloride, 228 mg of 4 dimethylaminopyridine and 482 mg of dicyclohexylcarbodiimide. The mixture was stirred for 36 hrs at ambient temperature under nitrogen, diluted with an equal volume of ether and filtered. The filtrate was evaporated.The residue was flash chromatographed on silica gel in hexane ethyl acetate 1 1 , after which the appropriate fractions were combined and evaporated. The residue was crystallized from hexane to give 286.5 mg 29.6 of product, mp 150 155 dec. ANALYSIS Calculated for C30H48N2O7. 65.65 C 8.83 H 5.10 NFound 65.68 C 0.91 H 5.22 N EXAMPLE 23 N,N Dimethylaminoacetoxy 8,13 epoxy 1 alpha ,6ss,9 alpha trihydroxy labd 14 en ll one 1 ,9dimethylformamide acetal 8,13 Epoxy 1 alpha ,6ss,7ss,9 alpha tetrahydroxylabd 14 en 11 one dimethylformamide acetal 758 mg was dissolved in 58 ml of dichloromethane and stirred at ambient temperature overnight, under nitrogen, along with N,N dimethylglycine hydrochloride 247.5 mg , 4 dimethylaminopyridine 227.5 mg and dicyclohexylcarbodiimide 962.4 mg . The mixture was diluted with an equal volume of ether, filtered and evaporated.The residue was flash chromatographed on silica gel in hexane ethyl acetate methanol 10 2 1 The appropriate fractions were combined and evaporated. The resultant oil was dried under vacuum at 2 to give 800 mg 89.0 of product, mp 55680. ANALYSIS Calculated for C27H44N207 63.73 C 8.74 H 5.50 NFound 63.56 C 8.86 H 5.33 N EXAMPLE 24 1 Piperidinoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxylabd 14 en 11 one hydrochloride hemietherate 2ss 1 Piperidinoacetoxy 8,13 epoxy 1 alpha , 6ss, 9 alpha trihydroxy labd 14 en ll one l,9 dimethylformamide acetal 259.5 mg was dissolved in 5 ml of methanol and 5 ml of 80 acetic acid. The mixture was stirred under nitrogen at ambient temperature overnight, evaporated, diluted with water, neutralized with sodium bicarbonate solution, and extracted with ether. The ether extracts were combined, dried over anhydrous sodium sulfate, filtered and evaporated.The residue was dissolved in anhydrous ether, from which the hydrochloride salt was precipitated by addition of etheral hydrogen chloride. The precipitate was filtered, washed with anhydrous ether and dried under vacuum at 1180 for 1 hr to afford 168.2 mg 62.6 of product, mp 190 194 .ANALYSIS Calculated for C29H49ClN07 5 61.4Q8C 8.72 H 2.47 N Found 61.11 C 8.88 H. 2.598N EXAMPLE 25 1 alpha N t Butylaminoacetoxy 5 alpha ,9 alpha dihydroxy 8,13 epoxy 7ss tetra hydrofurano 2 yloxy 1adb 14 mn 11 one hydrochloride hydrate 8,3 Epoxy 1 alpha ,5ss,9 alpha rihydroxy 7ss 2 tetrahydrofuranoyloxy labd 14 en 11 one 2g mg war dissolved in dry dichloromethane 2 ml along with dimethylanfline 58.7 1 with cooling to 50. A solution of bromoacetyl bromide 49.1 1 in dry dichloromethane 2 ml was added dropwise over 0.3 hr to the solution After 1 hr at 5 , the mixture was allowed to warm to ambient temperature and poured onto a mixture of ice and saturated aqueous sodium bicarbonate solution. The solution was extracted with ethyl acetate and the organic extract was dried over anhydrous sodium sulfate, filteredf and evaporated. The residue was dissolved in dry dichloromethane 1 mi and stirred under nitrogen. A solution of t butylamine 91.2 1 in ethyl acetate Z ml was added. The mixture was stirred at ambient temperature overnight, diluted with dichloromethane 16 ml and washed with water followed by saturated aqueous sodium bicarbonate solution.The dichioromethane Iayer was evaporated and the residue was flash ehrcuatograpbed on silica gel in hexane ethyl acetate methanol 15 19 9.81 . The appropriate fractions were combined and evaporated. The residue was dissolved in anbydrous ether and treated with ethereal hydrogen chloride. The precipitate was filtered, washed with ether and dried under vacuum to give 1.22 sg 44.9 of product, mp 165 170 .ANALYSIS Calculated for C31H49NO9.HCl.H2O 58.78 C 8.28 H 2.21 NFound 98.96 C 8.92 H 2.12 N EXAMPLE 26 6ss,3 alpha Dihydroxy 8,13 epoxy 3 alpha N 2 propylaminoacetoxy 7ss tetra hydrofurano 2 yloxy labd 14 en 11 one hydrochloride hydrate 8,13 Epoxy 7ss 2 tetrahydrofuranoyloxy 1 alpha ,6ss,9 alpha trihydroxy labd 14 en 11 one 400 mg was combined with N,N dimethylaniline 117.4 l in dry dichloromethane 4 ml at 5 C under nitrogen. A solution of bromoacetyl bromide 198.2 l in dry dichloromethane 4 ml was added and the mixture was stirred at that temperature for 2 hr. The mixture was allowed to warm to ambient temperature and was quenched with ice water. Th. mixture was extracted into ethyl acetate ,and the organic phase washed with dilute aqueous sodium bicarbonate solution, dried over anhydrous sodium sulfate, filtered and evaporated. The residue was dissolved in dry dichloromethane 2 ml . One ml .of the resultant mixture was added to a solution of 2 propylamine 146.2 l in ethyl acetate 1 ml .The mixture was stirred under nitrogen at ambient temporature overnight. The mixture was washed with 1 ml of saturated aqueous sodium bicarbonate solution, the layers were separated, and the phase was flash chromatographed on silica gel in hexane ethyl acetate methanol 10 10 0.1 . The appropriate fractions were combined and evaporated. The residue was dissolved in anhydrous ether and treated with ethereal hydrogen chloride to provide 106 mg 37.5 of product, mp 144 155 . ANALYSIS Calculated for C38H55ClNO16 58.89 C 8.14 H 2.25 NFound 58.29 C 8.83 H 2.25 N EXAMPLE 27 6ss,9 alpha Dihydroxy 8,13 epoxy 1 alpha 4 morpholinoacetoxy 7ss 2 tetrahydrofurano 2 yloxy labd 14 en 11 one hydrochloride hemihydrate 8,13 Epoxy 1 alpha ,6ss,3 alpha trihydroxy 7ss 2 tetrahydrofuran oyloxy labd 14 en 1l one 4S mg was combined with N,N dimethylaniline 117.4 l in dry dichloromethane t4 ml at O under nitrogen. A solution of bromoacetyl bromide 98.2 l in dry dichloromethane 4 ml was added and the mixture was stirred at 50 for 2 br. The mixture was, allowed to warm to ambient temperature. quenched with ice water, and extracted into ethyl acetate. The organic phase was washed with dilute aqueous codium bicarbonate solution and dried over anhydrous sodium sulfate, filtered and evaporated. The residue was dissolved in dry dichloromethane 2 ml . One m1 of the resultant mixture was doused to a solution of morpholine 149. l in ethyl acetate 1 mi . The mixture was stirred under nitrogen at ambient temperature overnight The mixture was extracted with saturated aqueous sodium bicarbonate solution 1 ml . The organic phase was flash chromatographed on silica gel in hexane ethyl acetate 1 1 . The appropriate fractions were combined and evaporated.The residue was dissolved in anhydrous ether and treated with ethereal hydrogen chloride to provide 110 mg 49.1 of product. mp 156 154 .ANALYSIS Calculated for C32H49ClNO10.5 58.24 C 7 74 H 2.10 NFound 58.34 C 7 76 H 2.17 N EXAMPLE 28 8,13 Epoxy 7ss 2 methyltetrahydrofurano 2 yxloxy 1 alpha ,6ss,9 alpha trihydroxy labd 14 en 11 one 8,13 1 alpha ,6ss,7ss,9 alpha tetrahydroxylabd 14 en 11 one 500 mg was combined with 4 dimethylaminopyridine 174.3 mg ,2 methyl 2tetrahydrofuoric acid 179.2 mg and dicyclohexylcarbodiimide 300.3 mg in of dichloromethane, 50 ml . The mixture was stirred at ambient temperature overnight under nitrogen. The mixture was diluted with an equal volume of ether, filtered and evaporated. The residue was flash chromatographed on silica gel in dichloromethanesmethanol 10 0.4 .The appropriate fractions were combined, evaporated and the residue was crystallized from cyclobenzane ether to yeld 354.6 mg 32.0 of product, mp 154 164 ANALYSIS Calculated for C26H49O8 64.96 C 0.41 HFound 65.04 C 0.49 H EXAMPLE 29 3 alpha N t Butylaminoacetoxy 6ss,9 alpha dihydroxy 0,13 epoxy 7ss 2 methylterahydrofurano 2 yloxy 1abd 14 en 11 one hydroclorhyde hydrate 8,13 Epoxy 1 alpha ,6ss,9 alpha trihxydroxy 7ss 2 methyltetrahydro furano 2 yloxy labd 14 en 11 one 164.0 mg was dissolved in dicloromethane 2 ml with X,N dimethylanilide 44.3 mg at 0 C A solution of bromoacetyl bromide 83.4 ng in dichloromethane 2 ml was sodded dropwise over 15 min.The mixture was stirred For 2 hr with gradual warming to room temperature. The mixture was partitioned between water and ethyl acetate. The organic layer was washed with saturated aqueous sodium bicarbonate solution, dried over anhydrous sodium sulfate, filtered and evaporated. The residue was dissolved in dichloromethane 1 ml and stirred with a solution of t butyl amine 100 mg in ethyl acetate 2 ml under nitrogen. The mixture was stirred at ambient temperature overnight, diluted with dichloromethane and washed with saturated aqueous sodium bicarbonate solution. The organic layer vas separated and evaporated. The residue was flash chromatographed on silica gel in hexane ethyl acetate methanol 10 10 9.1 The appropriate fractions were combined and evaporated.The residue was dissolved in anhydrous ether a,nd treated with ethereal hydrogen chloride to afford 65 mg t29.3 of product, mp 156 161 .ANALYSIS.Calculated for C32H54ClNO19 59.28 C 8.41 H 2.16 NFound 39.47 C S.41 H 2.79 N EXAMPLE 39 7 alpha 2,2 Dimethyl 1,3 dioxolano 4 yloxy 8,13 epoxy 1 alpha ,6ss,9 alpha trihydroxvlabd 14 en ll one 8,13 Epoxy 1 alpha ,6ss,7ss,9 alpha tetrahydroxylabd 14 on 11 one 500 mg was dissolved 1n dichlormethane 50 ml and strred with 2,2 dimethyl 1,3 dioxolane 4 carboxylic acid potassium salt 250 mg , 4 dimethylyminopyridine hydrochloride 215.3 mg and dicyclohexylcarbodiimide 294.3 mg overnight, at ambient temperture under nitrogen. The mixture was diluted with an equal volume of ether and filtered. The filtrate was evaporated.The residue was flash chromatographed on e ilica gel in hexane etbyl acetate 3 1 . The appropriate fractions were combined and evaporated to afford 350.8 mg 50.5 of product, mp 100 softening . ANALYSIS Calculated for C25H49O9 62.87 C 8.13 HFound 63.17 C 8.59 H IXAMPLI 31 ,3 Dihydroxypropionyloxy 8,13 epoxy 1 alpha ,6ss,9 alpha trihydroxylabd 14 en ll one 6,13 Epoxy 7 alpha 2,2 dimethyl 1,3 dioxolano 4 yloxy 1 alpha ,6ss,9 alpha trihydroxylabd 14 en 11 one 204 mg was dissolved in a mixture of 8 acetic acid 2 ml and methanol 9.4 ml , under nitrogen, and the mixture was stirred at ambient temperature for 3 days.The mixture was evaporated. The residue was flash chromatographed on silica gel in hexane ethyl acetate methanol 10 10 9.01 . The appropiate fractions where combined and evaporated. The residue was crystallized from cyclohexane ether to afford 85.6 mg 45.3 of product, mp 162 178 ANALYSIS Calcuted for C23H36O9 68.97 C 7.96 HFound 69.46 C 8.05 H EXAMPLE 32 1 alpha N t butylaminoacetoxy 6ss,9 alpha , dihydroxy 7ss 2,2 dimethyl 1,3 dixolano 1 yloxy 8,11 epoxylabd 14 en 11 one 7 alpha 2,2 dimethyl 1,3 dixolano 1 yloxy 8,13 epoxy 1 alpha ,6ss,9 alpha trihydroxylabd 14 en 11 one 500 mg was disolved in dry dichlormethan 6 ml with N,N dimethylaniline 137.6 l under nitrogen.The mixture was cooled to 50 Bromacetyl bromide 105.6 l dissolved in dry dichloromethane 6 ml was added to the stirred solution and the mixture was allowed to stand for 2 hr with gradual warming to ambient temperature. The mixture was partitioned between ether and water The organic phase was separated, washed with saturated aqueous sodium bicarbonate solution, dried over anhydrous sodium sulfate1 filtered, and eveporated. The residue was dissolved in dichloromethane 5 ml and stirred under nitrogen with t butylamine 214.3 ml dissolved in 19 ml of ethyl acetate. Tne ,sixture was allowed to stand at ambient temperature overnight. The mixture gas partitioned hetween ethyl acetate and saturated aqueous sodium bicarbonate solution. The organic layer was evaporated.The residue was flash chromatographed on silica gel in hexane ethyl acetate methanol 10 10 9.1 The appropriate fractions were combined and evaporated. The residue was dissolved in ether and treated with ethereal hydrogenchloride to affont 383.1 mg 45.2 of product, mp 179 176 dec .ANALYSTS Calculated for C32H54ClNO11 57.85 C 8.21 H 2.11 NFound 58.95 C 8.92 H 2.89 N EXAMPLE 33 8,11 Epoxy 7ss pyroglytamoyloxy 1 alpha ,6ss,9 alpha trihyxdroxylabd 14 en 11 one 8,11 Epoxy 1 alpha ,6ss,7ss,9 alpha trihyxdroxylabd 14 en 11 one 500 mg was disolvet in dichloromethane 50ml and stirred together with pyroglutamic acid 175.3 mg , 4 dimethylaminopyridine 174.3 mg and dicyclohexylcarbodiimide 308.3 mg overnight at ambient temperature, under nitrogen. The mixture was diluted with an equal volume of ether and filtered.The filtrate was evaporated. he residue was flash chromatographed on silica gel in hexane ethyl acetate methanol 10 10 1 . The appropriate fractions were combined and evaporated. The residue was dissolved in ether and precipitated with hexane to afford 266.9 mg 41.9 of product, mp 150 60 .ANALYSIS Calculated for C25H37N08 62.69 C 7.79lH 2.S2 N Found 62.94 C 7,92 H 2.66 N EXAMPLE 34 8,11 Epoxy 7ss N 2 nitrophenylsulfphenyl prolyloxy 1 alpha ,6ss,9 alpha trihyxdroxylabd 14 en 11 one 8,13 Epoxy 1 alpha ,6ss,7ss,9 alpha trihyxdroxylabd 14 en 11 one 750 mg was combined with 4 N,N dimethylamino pyridine hydrochloride 323 mg , N 2 nitrophenylsulfphenyl proline dicyclohexyl ammonium salt 917.2 mg and dicyclohexylcarbodiimide 505,0 mg in dichloromethane 50 ml . The mixture was stirred at ambient temperature under nitrogen overnight. The mixture was diluted with an equal volume of ether, filtered and evaporated.The residue was flash chromatographed on silica gel in dichloromethane methanol 10 0.2 . The appropriate fractions were combined and evaporated to dryness. The residue was crystallized from hexane ether to afford 880.3 mg of product.mp 125 129 .ANALYSIS Calculated for C31H42N2O9S 60.17 C 6.86 H 4.52 NFound 60.69 C 7.09 H 4.53 N IXAXPLI 35 8,13 Epoxy 7ss prolyloxylabd 14 en 11 one 8,13 Epoxy 7ss N 2 nitrophanylsulfenyl prolyloxy 1 alpha ,6ss,6 alpha trihydroxylabd 14 en 11 one 489 mg was dissolved in ether 20 ml .Saturated ethereal hydrogen chloride 2 ml was added and the mixture was stirred for 15 min. The precipitato was filtered, washed with ether and dried at 890 to yield 125 ng 31.9 of product, mp 185 195 ANALYSIS Calculated for C25H42ClNO8 57.73 C 8.16 H 2.69 NFound 58.16 C 7.89 H 3.24 N EXAMPLE 36 8,13 Epoxy 6 tetrahydrofurano 2 yloxy 1 alpha ,7ss,9 alpha trihydoxylabt14 en 11 one 8,13 Epoxy 7ss tetrahydrofurano 2 yloxy 1 alpha ,6ss,9 alpha trihydroxylabd 14 en 11 one 200 mg was dissolved in dry tetrahydrofuran 3 ml and maintained at 75 Lithium bis dimetylsilyl amide 492.2 l 1,1 M im tetrahydrofuran was added and the mixture was warmed to 0 .The mixture was stired for 3 hr after which adittional lithium bis trimethylsilyl amide 200 1, 1 M in tetrabydrofuran was added. After a total time of 6 hr f the reaction was flash chromatographed on silica gel, in hehane ethyl acetate methanol 2 1 0.01 to afford 68.9 mg 34.9 of product, mp 199 115 ANALYSIS Calculated for C25H38O0 64.34 C 8.23 HFound 64.92 C 8.16 H EXAMPLE 37 1 alpha N t Butylaminoacetoxy 7ss,9 alpha dihydroxy 8,13 ep tetrahydrofurano 2 yloxylabd 14 en 11 one To a stirred solution of 8,13 epoxy 6 alpha tetrahydrofurano 2 yloxy 1 alpha ,7ss,9 alpha trihydroxylabt 14 en 11 one 300 mg in dry dichlomethane 3 ml comtaining N,N dimethylaniline 0.11 ml in an ice bath, under nitrogen, was added dropwise a solution of bromoacetyl bromide 9.g75 ml in dichloromethane 6 ml . The solution was stirred at PIO for 1 hr.The solution was poured into ice water ethyl acetate, extracted with ethyl acetate, washed with cold sodium bicarbonate solution, water and dried over anhydrous sodium sulfate Filtration followed by evaporation of solvent provided an oil which was dissolved in dichloromethane 3 ml and added to a solutton of t butylamine 9.3 g in ethyl acetate 3 ml . The mixture was stirred overnight, poured into ice wate, ethyl acetate. The layers were separated and the organic pahe was washed twice with water, saturated sodium chloride solution and dried over anhydrous sodium sulfate. Piltration followed by evaporation of solvent provided an oil.The oil was, dissolved in other and treated with ethereal hydrogen chloride to provide 169 ing 41.4 of product, mp 165 176 .ANALYSIS Calculated for C31N49NO9.HCl.H2O 58.71 C 8.26 H 2.21 NFound 58.47 C 8.91 H 2.13 N EXAMPLE 38 8,13 Epoxy 6 2,2 dimethyl 1,3 dioxolano 4 yloxy 1 alpha ,7ss,9 alpha trihydroxylabd 14 en 11 one 8,13 Epoxy 1 7ss 2,2 dimethyl 1,3 dioxolano 4 yloxy 1 alpha ,6ss,9 alpha trihydroxylabd 14 en 11 one 1.4 g was disolved in dry tetrahydrofuran t30 ml under nitrogen and cooled to 5 . Lithium bis trimethylsilyl amide 2.82.ml, 1 M in tetrahydrofuran was added, with stirring. The mixture was allowed to stand for 2 hr at SOC. The product was partitioned between saturated aqueous sodium bicarbonate solution and ethyl acetate.The organic layer was separated, dried over anhydrous sodium sulfate, filtered and evaporated. The residue was dissolved in hexane ethylacetate 3 11 and flash chromatographed on silica gel eluting with 899 ml of hexane ethyl acetate 3 1 followed by 999 ml of hexane ethyl acetate 2 L . The appropriate fractions were combined and evaporated. The residue was crystallized from hexane ethyl acetate to provide 470 mg 33.6z of product, mp 119 1290. ANALYSIS Calculated for C26H47O9 62.87C 8.13 H Found 63.25C 8.26 H EXAMPLE 39 8,13 Epoxy 6 2,3 dihydroxypropionyloxy 1 alpha ,7ss,9 alpha trihydroxylabd B 14 en 11 one 8,13 Epoxy 1 6ss 2,2 dimethyl 1,3 dioxolano 4 yloxy 1 alpha ,6ss,9 alpha trihydroxylabd 14 en 11 one 389 m g was disolved in 86 acetic acid 4.5 ml and stirred with methanol 4.5 ml ot 590 for 2 days, under nitrogen. The solvent was evaporated and the residue was partitioned between chloroform and saturated sodium bicarbonate solution. The chloroform extracts were combined, dried over anhydrous sodium sulfate, filtered and evaporated. The residue was flash chromatographed on silica gel in dichloromethane methanol 19 1 . The appropriate fractions were combined, evaporated and the residue was dried under vacuum at 1990 overnight to afford 91 mg 25.3 of product, mp 225 235 . ANALYSIS Calculed for C23H36O9 68.50 C 7.96 HFound 59.87 C 7.88 H EXAMPLE 40 dimethylformamide acetal 8,13 Epoxy 1 alpha 6ss,7ss,9 alpha labd 14 en 11 one 1,9 dimethyl formamide acetal 1.059 9 was heated under reflux in toluene 25 ml contining N,N carbonyldiimidazole 0.50 g and triethylamine 9.55 ml . After 3 hr, the reaction mixture was evaporated and the residue was applied directly to a flash chromatograph. Zlution with 50 ethyl acetate hexane gave 0.976 g E78 of product after combination of the appropriate fractions. The analytical sample obtained by recrystallization from hexane had mp 138 140 . . ANALYSIS Calculed for C24H25NO7 64.12 C 7.85 H 3.17 HFound 63.91 C 7.98 H 3.68 H EXAMPLE 41 8,13 6 alpha methoxyacethoxy 1 alpha ,7ss,9 alpha labd 14 en 11 one To a stirred solution of 9.317 9 of 8,13 epoxy 7ss methoxyacethoxy 1 alpha ,6ss,9 alpha labd 14 en 11 one in tetrahydrofuran 75 ml was added 1 M lithium bis trimethylsilyl amide in hexanes 1.36 ml in an ice bath. The solution was stirred 1 hr at S01 poured into ice water and extracted with ethyl acetete. The organic extracts were washed three times with water, once with saturated sodium chloride solution and dried over. anhydrous sodium sulfate. Filtration followad by evaporation of solvent provided an oil.The oil war dissolved in a minimum volume of 35 ethyl acetate hexane and flash chromatogaphed on 200 g of silica gel. Zvaporation of solvent from the appropriate fractions provided 9.147 g 46.4 of product, mp 164 1650. ANALYSIS Calculated for C23H3608 52.71 C 7.76H Found 65.96 C 7.78 H EXAMPLE 42 7ss 1,2 3,4 Diisopropylidine D galacturonoyloxy 8,13 epoxy 1 alpha ,5ss,9 alpha trihydroxylabd 14 en 11 one 8,13 Epoxy 1 alpha ,6ss,7ss,9 alpha trihydroxylabd 14 en 11 one 500 mg , 1,2 3,4 diisopropylidine galacturonic acid 410 mg , 4 dimethylaminopyridine 189 mg and dicyclohexylcarbodiimide 35 mg were dissolved in dichloromethane 59 ml and stirred under nitrogen at ambient temperature overnight. The mixture was filtered and evaporated.The residue was triturated with ethyl acetate and filtered. The filtrate was evaporated and the residue vas flash chromatographed, on si lica gel in dichloromethane methanol 98 2 . The appropriate fractions were combined and evaporated . The residue was crystallized from hexane ether to afford 299 mg 24.6 of product, mp 229 233 .ANALYSIS Calculated for C32N48O12 61.31 C 7.76 NFound 68.96 C 7.79 H EXAMPLE 43 gamma 3 Dimethylphosphinyl propionyloxy 9,13 epoxy 3 alpha ,5ss,5 alpha trihydroxylabd 14 en 11 one A solution of 3,13 epoxy 5 alpha ,6ss,7ss,3 alpha tetrahydroxylabd 14 en 11 one 600 mg , 2 carboxyethyldimethylphosphine oxide 300 mg , dimethylaminopyridine 25 mg , dicyclohexylcarbodiimide 440 mg and dichloromethane 60 ml was stirred at room temperature for 16 hrs. The suspension was filtered and flash chromatographed without being concentrated on silica gel eluent 48 methanol dichloromethana . Concentration of the appropriate fractions provided 9.559 g 58.7 of product, mp 252 259 . ANALYSIS Calculated for C25H41O5F 89.98 C 5.26 HFound 69.32 C 8.91 H REACTION SCHEME A EMI39.1 EMI39.2 EMI39.3 wherein R6, R7, R10, R11, R12, R13, R19, R20 and are as hereinbeforedescribed. REACTION SCHEME B EMI40.1 wherein R3, R4, R5, R7, R11, R12, R13, and are as hereinbeforedescribed.